TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Covid patient gets ‘antibody cocktail’

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Mohali, May 30

Advertisement

An ‘antibody cocktail’ therapy was administered to a 72-year-old Covid positive patient at Fortis Hospital in Mohali today. The patient suffering from diabetes and a chronic disease had tested positive two days ago. He was administered one dose of the cocktail intravenously and is reportedly stable post-infusion.

Advertisement

The ‘antibody cocktail therapy’ is for those above the age of 65, who are isolating at home, have an SpO2 of 93, require no oxygen support, but are at a risk of developing a severe

form of the infection on account of their comorbidities such as obesity, diabetes, liver disease, heart ailments and chronic lung disease.

Dr Zafar Ahmed, Senior Consultant, Critical

Advertisement

Care, Pulmonology and Chest and Sleep Medicine, said: “The cocktail has casirivimab and imdevimab, which are monoclonal antibodies that specifically block the spike protein of SARS-CoV-2, preventing the coronavirus attachment and entry into human cells.” — TNS

Advertisement
Show comments
Advertisement